References
1. Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et al. Atrial fibrillation. Nature reviews Disease primers. 2016;2:16016.
2. Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circulation Cardiovascular quality and outcomes. 2012;5(1):85-93.
3. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. The American journal of cardiology. 2013;112(8):1142-7.
4. Tu K, Nieuwlaat R, Cheng SY, Wing L, Ivers N, Atzema CL, et al. Identifying Patients With Atrial Fibrillation in Administrative Data. The Canadian journal of cardiology. 2016;32(12):1561-5.
5. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiology and drug safety. 2012;21 Suppl 1:141-7.
6. Kleinbaum DG, Kupper L, Morgenstern H. Epidemiologic research. Principles and quantitative methods. Van Nostrand Reinhold: New York City, NY, USA. 1982.
7. Statistical-Analysis-Software. Base SAS 9.4 procedures guide: statistical procedures, 2nd Edition. SAS, 2013: Cary, NC, USA. 2013.
8. CDC. Division for Heart Disease and Stroke Prevention. Atrial fibrillation fact sheet. Reported in https:// www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm. Page last reviewed: Aug 22, 2017. 2017.
9. Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013;15(10):1436-44.
10. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213-20.
11. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013;15(4):486-93.
12. Johansson C, Hagg L, Johansson L, Jansson JH. Characterization of patients with atrial fibrillation not treated with oral anticoagulants. Scandinavian journal of primary health care. 2014;32(4):226-31.
13. Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart (British Cardiac Society). 2013;99(16):1166-72.
14. Shaikh F, Pasch LB, Newton PJ, Bajorek BV, Ferguson C. Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation. Current cardiology reports. 2018;20(5):32.
15. Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nature reviews Cardiology. 2017;14(11):627-8.
16. Yoon M, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, et al. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. Thrombosis and haemostasis. 2019;19(10):1695-703.
17. Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. Mayo Clinic proceedings. 2019;94(7):1261-7.
18. Guo Y, Lane DA, Wang L, Zhang H, Wang H, Zhang W, et al. Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2020;75:1523-34.